                         SEQUENCE LISTING

<110>  Universiteit Gent
 
<120>  Method for cross-linking peptides

<130>  UG-047-PCT

<150>  10196898.0
<151>  2010-12-23

<160>  18    

<170>  PatentIn version 3.3

<210>  1
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  1

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210>  2
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  Furan
<222>  (1)..(1)

<400>  2

Ala Trp Ser His Pro Gln Phe Glu Lys 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  Furan
<222>  (9)..(9)

<400>  3

Trp Ser His Pro Gln Phe Glu Lys Ala 
1               5                   


<210>  4
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  Furan
<222>  (8)..(8)

<400>  4

Trp Ser His Pro Gln Phe Glu Ala 
1               5               


<210>  5
<211>  20
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  5

Val Glu Asp Arg Thr Val Asp Val His Ile Arg Arg Leu Arg Lys Ala 
1               5                   10                  15      


Leu Glu Pro Gly 
            20  


<210>  6
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  6

Ala His Asn Leu Ala 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide


<220>
<221>  Furan
<222>  (2)..(2)

<400>  7

Leu Ala Gly Lys Val 
1               5   


<210>  8
<211>  3
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  8

Gly Lys Val 
1           


<210>  9
<211>  20
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  9

Val Glu Asp Arg Thr Val Asp Val His Ile Arg Arg Leu Arg Lys Ala 
1               5                   10                  15      


Leu Glu Pro Gly 
            20  


<210>  10
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  10

Thr Val Asp Val His Ile Arg Arg Leu Arg Lys Ala Leu Glu Pro Gly 
1               5                   10                  15      


<210>  11
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  11

Val Glu Asp Thr Val Asp 
1               5       


<210>  12
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  12

His Ile Arg Arg Leu Arg Lys Ala Leu Glu Pro Gly 
1               5                   10          


<210>  13
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  13

Val Glu Asp Arg Thr Val Asp Val 
1               5               


<210>  14
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  14

Ile Arg Arg Leu Arg Lys Ala Leu Glu Pro Gly 
1               5                   10      


<210>  15
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  15

Val Glu Asp Arg Thr Val Asp Val His Ile Arg 
1               5                   10      


<210>  16
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  16

Leu Arg Lys Ala Leu Glu Pro Gly 
1               5               


<210>  17
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  17

Thr Pro Lys Arg Pro Arg Gly Arg Pro Lys Lys 
1               5                   10      


<210>  18
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic peptide

<400>  18

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


